Table 2 Patient clinical characteristics of study groups after propensity score matching
2OPMT group | CSWWD group | Std. Diff.* | |||
|---|---|---|---|---|---|
N | 5,338 | 100% | 5,338 | 100% | |
Comorbidities, N/% | |||||
Alcohol abuse | 183 | 3.40% | 183 | 3.40% | 0.000 |
Cancer | 45 | 0.80% | 55 | 1.00% | 0.019 |
Cardiac arrhythmias | 1,291 | 24.20% | 1,344 | 25.20% | −0.023 |
Chronic pulmonary disease | 1,287 | 24.10% | 1,275 | 23.90% | 0.005 |
Coagulopathy | 399 | 7.50% | 395 | 7.40% | 0.003 |
Congestive heart failure | 1,813 | 34.00% | 1,821 | 34.10% | −0.003 |
Deficiency anemia | 114 | 2.10% | 118 | 2.20% | −0.005 |
Depression | 549 | 10.3% | 552 | 10.3% | −0.002 |
Diabetes, complicated | 1,496 | 28.00% | 1,502 | 28.10% | −0.003 |
Diabetes, uncomplicated | 937 | 17.60% | 933 | 17.50% | 0.002 |
Drug abuse | 174 | 3.30% | 176 | 3.30% | −0.002 |
Hypertension, uncomplicated | 2,675 | 50.10% | 2,676 | 50.10% | 0.000 |
Hypertension, complicated | 2,123 | 39.80% | 2,113 | 39.60% | 0.004 |
Hypothyroidism | 687 | 12.90% | 673 | 12.60% | 0.008 |
Liver disease | 150 | 2.80% | 160 | 3.00% | −0.011 |
Obesity | 1,676 | 31.40% | 1,687 | 31.60% | −0.004 |
Neurological disorders | 162 | 3.00% | 156 | 2.90% | 0.007 |
Paralysis | 13 | 0.20% | 11 | 0.20% | 0.008 |
Peripheral vascular disease | 958 | 17.90% | 985 | 18.50% | −0.013 |
Pulmonary circulation disorders | 408 | 7.60% | 418 | 7.80% | −0.007 |
Renal failure | 1,181 | 22.10% | 1,196 | 22.40% | 0.007 |
RA/collagen vascular diseases | 152 | 2.80% | 138 | 2.60% | 0.016 |
Valvular disease | 1,870 | 35.00% | 1,892 | 35.40% | −0.009 |
Weight loss | 101 | 1.90% | 108 | 2.00% | −0.009 |
CCI, N/% | |||||
0 | 694 | 13.00% | 701 | 13.10% | −0.004 |
1–2 | 2,450 | 45.90% | 2,432 | 45.60% | 0.007 |
3–4 | 1,298 | 24.30% | 1,309 | 24.50% | −0.005 |
5+ | 896 | 16.80% | 896 | 16.80% | 0.000 |